Qualigen Therapeutics, Inc. announced that on May 17, 2021, the Board elected Tariq Arshad as its Senior Vice President and Chief Medical Officer. This is a newly-created position. Mr. Arshad was previously Global Head of Medical Affairs and Clinical Research with Becton Dickinson Biosciences (2019-2021), Head of Medical Affairs, Immunology, Global Markets for Sanofi Genyzyme (2018-2019) and Chief Medical Officer, Head of Clinical Research and Medical Affairs for Humanigen, Inc. (2016-2018). Before then, he held medical leadership positions with XOMA Corporation, Genentech, Inc., Merck & Co., Inc. and Pfizer Inc. Mr. Arshad is a medical doctor with a specialization in oncology and also holds a M.B.A. degree.